1. Home
  2. BRW vs CCCC Comparison

BRW vs CCCC Comparison

Compare BRW & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRW
  • CCCC
  • Stock Information
  • Founded
  • BRW 1987
  • CCCC 2015
  • Country
  • BRW United States
  • CCCC United States
  • Employees
  • BRW N/A
  • CCCC N/A
  • Industry
  • BRW Trusts Except Educational Religious and Charitable
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRW Finance
  • CCCC Health Care
  • Exchange
  • BRW Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • BRW 308.8M
  • CCCC 423.8M
  • IPO Year
  • BRW N/A
  • CCCC 2020
  • Fundamental
  • Price
  • BRW $7.18
  • CCCC $6.48
  • Analyst Decision
  • BRW
  • CCCC Buy
  • Analyst Count
  • BRW 0
  • CCCC 7
  • Target Price
  • BRW N/A
  • CCCC $8.71
  • AVG Volume (30 Days)
  • BRW 222.1K
  • CCCC 2.1M
  • Earning Date
  • BRW 01-01-0001
  • CCCC 08-06-2024
  • Dividend Yield
  • BRW 15.59%
  • CCCC N/A
  • EPS Growth
  • BRW N/A
  • CCCC N/A
  • EPS
  • BRW N/A
  • CCCC N/A
  • Revenue
  • BRW N/A
  • CCCC $20,036,000.00
  • Revenue This Year
  • BRW N/A
  • CCCC $26.24
  • Revenue Next Year
  • BRW N/A
  • CCCC N/A
  • P/E Ratio
  • BRW N/A
  • CCCC N/A
  • Revenue Growth
  • BRW N/A
  • CCCC N/A
  • 52 Week Low
  • BRW $7.15
  • CCCC $1.06
  • 52 Week High
  • BRW $8.30
  • CCCC $11.88
  • Technical
  • Relative Strength Index (RSI)
  • BRW 53.46
  • CCCC 62.05
  • Support Level
  • BRW $7.12
  • CCCC $5.81
  • Resistance Level
  • BRW $7.36
  • CCCC $7.66
  • Average True Range (ATR)
  • BRW 0.11
  • CCCC 0.57
  • MACD
  • BRW 0.03
  • CCCC 0.15
  • Stochastic Oscillator
  • BRW 60.87
  • CCCC 64.30

About BRW Saba Capital Income & Opportunities Fund SBI

Saba Capital Income & Opportunities Fund t is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Share on Social Networks: